The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Dalian Deep Blue Peptide Technology R&D Co., Ltd., established on 2015-06-09, Business scope includes general items:Biological product,Research and development of daily chemical products,Production(limited production),Sales and related technology transfer,Technical Advisory Services;drinks,Candy production technology transfer,Technical Advisory Services;Research and development of microbial preparation production technology,technology transfer,Technical Advisory Services;Acquisition of agricultural and sideline products;Aquatic product processing(limited production);seafood,Aquatic products,food,Pre-packaged food,drinks,candy,refrigerated frozen food,Production of cosmetics and hygiene products(limited production)and sales;And use the Internet to engage in the business activities of the above commodities;Unmanned vending machine sales,lease;Domestic general trade;goods,Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Guangzhou Qinglan Biotechnology Co., Ltd., established on 2015-08-17, Business scope includes technology research and development of biochemical products;Biomass Energy Technology Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology promotion service;Cosmetics Retail;Cosmetics Wholesale;internet sales(Except for products that require a license for sale);Disinfectant sales(Free of Hazardous Chemicals);Health Care Services(non-medical);Sales of hygiene products and single-use medical products;Cosmetic production;Production of hygiene products and single-use medical products;Disinfectant production(Free of Hazardous Chemicals);Internet Information Service for Medical Devices

Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Nanjing Zelang Biotechnology Co., Ltd., established on 2009-08-04, Business scope includes product development in the field of biotechnology,processing,Sales;Chinese herbal medicine planting;Agricultural product planting,Sales and technical promotion;Acquisition of agricultural and sideline products,Sales;Food additive production,Sales(No pre-licensed items);Development of plant extracts,processing,Sales and related technology transfer and service;food production,Health food production and sales;Cleaning Products,cosmetic,Disinfectant research and development,Sales(No pre-licensed items);Pre-packaged food,Wholesale and retail of bulk food;Primary processing of agricultural products,Sales;Equipment development and sales;Chemical Products(Free of Hazardous Chemicals),Pharmaceutical Intermediates(Free of Hazardous Chemicals)Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Food import and export;Warehousing services for customs-supervised goods(Free of Hazardous Chemicals);Technology Import and Export;Import and export agency;Import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Aesthetic Technology (Beijing) Co., Ltd. (doing business as Aesthetic International Holdings Group Ltd) is a Chinese company located in Beijing with a presence in Hong Kong. The firm engages in research and development of bio-cosmetics and health care products. It was founded in 2002 by Guang Chen and Dong Hui Liu. Guang Chen has been the CEO since that date. Aesthetic Technology (Beijing) Co., Ltd. controls a large interest in NextEye Co., Ltd. (23.20 %).

Guilin Dekun Biotechnology Co., Ltd., established on 2014-04-29, Business scope includes plant extracts(persimmon tannin)research and development,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany.

Nanjing Zelang Pharmaceutical Technology Co., Ltd., established on 2008-01-08, The business scope includes the development of plant extracts,processing,Sales and related technology transfer and service;medicine,food,Health food research and development;Cosmetic sales,Primary Agricultural Sales;cereals,vegetable,planting of flowers;Promotion of planting technology of Chinese herbal medicines.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Boya Stem Cell Technology Co. Ltd. develops stem cell technology products. The company is headquartered in Wuxi, China.

Jilin Guorui Pharmaceutical Co., Ltd., established on 2003-03-12, Business scope includes antibiotics,Chinese patent medicine,Chinese herbal medicine,Chinese Herbal Medicine,Chemical raw materials and their preparations,Biological product(vaccine,Except refrigerated and frozen medicines)wholesale,one type,Class II,Wholesale of Class III Medical Devices,food,Healthy food,Cosmetics Wholesale;Foreign import and export trade;Health Information Consultation;Enterprise Marketing Planning,Corporate Image Planning,market survey;Business Management Consulting,Conference Services;Computer software technology development,technology transfer,technical consulting,Technical Services;Domestic general trade;Drug information technology promotion service;trade agent.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan.

Wuhan Omega Biopharmaceutical Co., Ltd., established on 2013-11-07, Business scope includes pharmaceutical products,Chemical Products(Free of Hazardous Chemicals),biological products,Plant extracts,Pharmaceutical intermediates and raw materials,Food Safety Testing Products,raw material of food,food additives,Experimental Instrument Reagent(Does not contain dangerous goods),Healthy food,Pre-packaged food,drinks,Infant formula milk powder,Baby Products,Disinfectant,cosmetic,hygiene products,Research and development of new drugs,Sales;First,Sales of Class II Medical Devices;Pharmaceutical and Biotechnology Development,consultation service;Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Involved in licensing projects,It should be operated after obtaining the permission of the relevant department)

Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It focuses on medicine and health business. The company's products include Chinese and western medicine preparations, raw materials, and pharmaceutical packaging materials, mainly for the elderly chronic drug and women and children medication; cardiovascular and cerebrovascular drugs, and health products. It also involves in the cultivation of Chinese herbal medicines. Yabao Pharmaceutical Group was founded on January 26, 1999 and is headquartered in Beijing. China.

Wuhan Optics Valley Shiao Biotechnology Co., Ltd., established on 2011-06-24, Business scope includes biopharmaceutical development,Research and development of pharmaceutical excipients and vaccine adjuvants,Biotechnology consulting and technology transfer.(In the scope of the above, the state-owned special regulations need to be examined and approved. The project can only be operated after approval or with a valid license.)

Engages in aquaculture

Xinjiang Advance Glory Investment Co., Ltd., established on 2015-05-14, Business scope includes investment in the energy industry,agricultural investment,real estate investment,mining investment,business investment,Investment in education,tourism investment,Construction Industry Investment,Investment in environmental protection industry,Biotechnology R&D project investment,Realtor;food business;Health food sales;Food Internet Sales;food business(Selling prepackaged food);Food Internet Sales(Selling prepackaged food);liquor business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Medicinal Materials Co., Ltd., established on 1992-04-28, Business scope includes licensed projects:Drug Wholesale;food business;road freight transport(Contains dangerous goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Class I medical device,Chemical raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),cosmetic,Daily necessities,electronic product,Edible produce,Sales of seeds and seedlings,business inquiries,Self-owned housing sales and leasing,Engaged in the import and export of goods and technology,technology development,technology transfer,technical consulting,Technical Services,Technology Promotion,Technology Exchange,e-commerce(Not to engage in financial business),domesticated and bred sika deer,red deer(Limited to branch operations),Attached branch.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)